2001年5月8日 DEVELOPMENTAL BIOLOGY:
The Hottest Stem Cells Are Also
the Toughest
サイエンスの記事、少し長いですが引用します。ヒトのES細胞に関して、今、どのくらいまで仕事が進んでいるのか、大まかなことがつかめると思います。
濱田洋文
Gretchen Vogel DEVELOPMENTAL BIOLOGY:
The Hottest Stem Cells
Are Also the Toughest
Science 2001 April 20; 292: 429 (in News Focus)
[Summary] [Full Text] |
Although political uncertainty is rampant,
researchers are making progress in the effort
to tame human embryonic stem cells
DURANGO, COLORADO--In the United States, public funding for
work with embryonic stem cells looks ever
more uncertain, as the National Institutes
of Health has put on hold its process for
approving cell lines that government-funded
scientists can use (see p. 415). That move comes as the handful of privately
funded labs already using the cells are reporting
progress-- albeit limited--in manipulating
these temperamental cells.
Although the cells were first derived more
than 2 years ago, work has been frustratingly
slow; indeed, only a few researchers have
published any results with human embryonic stem (ES) cells.
Not only are ES cells fussy about their growing
conditions, but they also tend to differentiate
spontaneously into a range of cell types
other than the desired one, confounding research
efforts. But at a recent Keystone meeting
here,* researchers described new techniques to
get around these obstacles.
Several teams are tackling the "very
labor-intensive" process
of growing
human ES cells, as James Thomson
of the University
of Wisconsin, Madison, described
it. Most
researchers grow the cells on
a feeder layer
of mouse cells to keep them from
differentiating.
But before these cells can be
used to treat
disease in humans, researchers
need to come
up with a culture free of mouse
cells. Melissa
Carpenter and her colleagues
at Geron Corp.
in Menlo Park, California, reported
that
they have managed to grow cells
on Matrigel,
a commercially available gel
commonly used
to culture cells. They bathe
the cells in
a serum-free medium that is first
"conditioned"
by incubating it with irradiated
mouse cells.
The scientists do not yet know
what the mouse
cells add to the medium; they
are working
to characterize its active components.
If
they succeed, they might be able
to produce
a synthetic medium that could
keep the cells
dividing but not differentiating.
Stem cell researchers eagerly await the day
when they can grow an unlimited supply of
human liver cells. Not only would they be
extremely valuable for tests of drug toxicity,
but they might also be useful for treating
some liver diseases. Geron scientists have
taken a first step, reported Carpenter, coaxing
their ES cell lines to produce "hepatocyte-like"
cells. They first exposed the cells to sodium
butyrate, a chemical known to promote cell
differentiation. Many of the cells died,
Carpenter said, but when the team cultured
the survivors in media designed for growing
hepatocytes, many of them began to store
glycogen and express proteins typical of
liver cells. Although the results are promising,
Thomson cautions that liverlike cell markers
appear on other cell types as well: "If
they're really hepatocytes, it would be good.
It's not yet clear to me that they are."
Meanwhile, Thomson and his colleagues have
found an efficient way to transform
human
ES cells into neural epithelial
cells--precursors
of more mature cell types in
the brain. The
team allowed the ES cells to
cluster into
balls of cells called embryoid
bodies and
then exposed them to media designed
for neural
cells. Next they isolated a partially
differentiated
cell type from the embryoid bodies
and cultured
those cells with basic fibroblast
growth
factor. Ninety-six percent of
the resulting
cells expressed neural markers,
Su-Chun Zhang
and Thomson reported. When transplanted
into
the brains of newborn mice, the
cells migrated
to several brain regions and
showed signs
of developing into mature neurons
and glia,
the neuronal supporting cells.
Stem cell researchers would like to create
immune-neutral stem cells that
wouldn't trigger
rejection when transplanted into
a patient.
But that would require genetically
altering
ES cells. So far, that has proved
far trickier
in human cells than in their
mouse counterparts.
At the meeting, Joseph Gold of
Geron said
that he and his colleagues have
genetically
altered cell lines to express
green fluorescent
protein (GFP)--making them easier
to track
in animal transplantation experiments.
And
in a paper now in press, Nissim
Benvenisty
of the Hebrew University in Jerusalem,
Joseph
Itskovitz-Eldor of Rambam Medical
Center
in Haifa, Israel, and their colleagues
report
that they have created cells
that express
GFP only when they are undifferentiated.
This would enable the scientists
to weed
out cells that have already chosen
a developmental
path.
Ultimately, researchers hope to devise a
way to target genetic changes
precisely.
Several teams are working to
adapt so-called
homologous recombination--the
technique that
has made mouse ES cells such
a valuable tool
for geneticists--to human cells.
So far none
has reported success.
* "Pluripotent Stem Cells: Biology and
Applications," 6-11 February.
濱田洋文 |